These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7122246)

  • 1. [Treatment of bronchial asthma with small doses of papaverine combined with beta stimulators].
    Krasnowska M; Jankowska R
    Pneumonol Pol; 1982; 50(1-2):21-4. PubMed ID: 7122246
    [No Abstract]   [Full Text] [Related]  

  • 2. [Our experience in the treatment of bronchial asthma and asthmatic bronchitis with salbutamol].
    Valenti S; Mirabelli S; Canonica GW; Brusasco V
    Minerva Med; 1976 Mar; 67(16):1084-94. PubMed ID: 1264385
    [No Abstract]   [Full Text] [Related]  

  • 3. [Nocturnal asthma: inhalation treatment with high doses of salbutamol and beclomethasone].
    Rodríguez Sanchón B; Manresa F; Romero P; Cardona MJ
    Rev Clin Esp; 1986 Apr; 178(7):322-6. PubMed ID: 3738002
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of combined therapy efficacy with disodium cromoglycate and salmeterol in children with atopic bronchial asthma].
    Hofman J; Swiebocka E
    Pol Merkur Lekarski; 1997 Oct; 3(16):168-70. PubMed ID: 9461722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Physiopathological evaluation of the combined beclomethasone-salbutamol therapy].
    Carnimeo N; Resta O; Valerio G; Foschino MP
    Arch Monaldi; 1979; 34(1-2):49-54. PubMed ID: 554574
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of inhaled salbutamol with a combination of salbutamol and beclomethasone dipropionate in moderately severe asthma.
    Chhabra SK
    Indian J Chest Dis Allied Sci; 1994; 36(3):119-24. PubMed ID: 7737699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
    Baumgarten C; Geldszus R; Behre U; Peslis N; Trautmann M;
    Eur J Med Res; 2002 Jan; 7(1):1-7. PubMed ID: 11827834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effective combined therapy of selective beta 1-adrenergic antagonist and selective beta 2-adrenergic agonist in a patient with bronchial asthma and hypertrophic cardiomyopathy].
    Yukawa T; Numao T; Motojima S; Fukuda T; Ikemori R; Makino S; Shimizu T; Hayashi T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1984 Apr; 22(4):318-23. PubMed ID: 6541723
    [No Abstract]   [Full Text] [Related]  

  • 10. Intramuscular and intravenous albuterol in the treatment of asthma.
    Rebuck AS; Contreras M
    Clin Ther; 1982; 5(1):44-8. PubMed ID: 7127368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma?
    Koenig SM; Murray JJ; Wolfe J; Andersen L; Yancey S; Prillaman B; Stauffer J; Dorinsky P
    Respir Med; 2008 May; 102(5):665-73. PubMed ID: 18328683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Stimulators of the beta-adrenergic receptors in the therapy of bronchial asthma].
    Smolenskiĭ VS; Daniliak IG; Zaslavskiĭ ML
    Sov Med; 1974 Jul; 0(7):91-5. PubMed ID: 4153242
    [No Abstract]   [Full Text] [Related]  

  • 13. Out-of-hospital administration of albuterol for asthma by basic life support providers.
    Richmond NJ; Silverman R; Kusick M; Matallana L; Winokur J
    Acad Emerg Med; 2005 May; 12(5):396-403. PubMed ID: 15860692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid corticosteroid effect on beta(2)-adrenergic airway and airway vascular reactivity in patients with mild asthma.
    Mendes ES; Horvath G; Campos M; Wanner A
    J Allergy Clin Immunol; 2008 Mar; 121(3):700-4. PubMed ID: 18086493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sympathomimetics and theophylline: combined use?].
    Alvarez Sintes R; Alvarez Sintes R; Alvarez Castro MR
    An Med Interna; 1995 Sep; 12(9):438-41. PubMed ID: 8924548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salmeterol compared with current therapies in chronic asthma.
    Adinoff AD; Schwartz HJ; Rickard KA; Yancey SW; Swearingen BE
    J Fam Pract; 1998 Oct; 47(4):278-84. PubMed ID: 9789513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of adding multiple doses of oxitropium bromide to salbutamol delivered by means of a metered-dose inhaler with a spacer device in adults with acute severe asthma.
    Nakano Y; Enomoto N; Kawamoto A; Hirai R; Chida K
    J Allergy Clin Immunol; 2000 Sep; 106(3):472-8. PubMed ID: 10984366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adding long-acting beta-agonists to inhaled corticosteroids after discharge from the emergency department for acute asthma: a randomized controlled trial.
    Rowe BH; Wong E; Blitz S; Diner B; Mackey D; Ross S; Senthilselvan A
    Acad Emerg Med; 2007 Oct; 14(10):833-40. PubMed ID: 17898245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of salmeterol in the maintenance treatment of asthma.
    Nathan RA; Seltzer JM; Kemp JP; Chervinsky P; Alexander WJ; Liddle R; Mills R
    Ann Allergy Asthma Immunol; 1995 Sep; 75(3):243-8. PubMed ID: 7552926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma.
    Bleecker ER; Yancey SW; Baitinger LA; Edwards LD; Klotsman M; Anderson WH; Dorinsky PM
    J Allergy Clin Immunol; 2006 Oct; 118(4):809-16. PubMed ID: 17030231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.